Review article · 2026

In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities

Natacha Jugniot

European Journal of Medicinal Chemistry, 318, 119213 · Published 4 August 2026 · DOI 10.1016/j.ejmech.2026.119213

View at the publisherCite this paper

In brief

“In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities” is a 2026 review article by Natacha Jugniot, published in European Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
174
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jugniot, N. (2026). In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities. European Journal of Medicinal Chemistry, 318, 119213. https://doi.org/10.1016/j.ejmech.2026.119213

MLA 9

Jugniot, Natacha. “In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities.” European Journal of Medicinal Chemistry, vol. 318, 2026, p. 119213. https://doi.org/10.1016/j.ejmech.2026.119213.

Chicago

Jugniot, Natacha. 2026. “In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities.” European Journal of Medicinal Chemistry 318: 119213. https://doi.org/10.1016/j.ejmech.2026.119213.

Harvard

Jugniot, N. (2026) ‘In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities’, European Journal of Medicinal Chemistry, 318, p. 119213. doi:10.1016/j.ejmech.2026.119213.

IEEE

N. Jugniot, “In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities,” European Journal of Medicinal Chemistry, vol. 318, p. 119213, 2026, doi: 10.1016/j.ejmech.2026.119213.

BibTeX

@article{jugniot2026vivo,
  title     = {{In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities}},
  author    = {Jugniot, Natacha},
  journal   = {European Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {318},
  pages     = {119213},
  doi       = {10.1016/j.ejmech.2026.119213},
  url       = {https://doi.org/10.1016/j.ejmech.2026.119213}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • in vivo imaging
  • tissue distribution
  • cellular uptake
  • endosomal escape
  • lymphatic transport
  • particle size effects
  • ionizable lipids
  • positron emission tomography tracers

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Jugniot, N. (2026). In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities. European Journal of Medicinal Chemistry, 318, 119213. https://doi.org/10.1016/j.ejmech.2026.119213

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Natacha Jugniot.

What is the DOI of this paper?

10.1016/j.ejmech.2026.119213, permanently at https://doi.org/10.1016/j.ejmech.2026.119213. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.